Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-15

Clinical Trial Update: Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation [NA]

View source ↗

Summary

A clinical trial update comparing 200 mg versus 400 mg vaginal progesterone for preventing preterm labor in twin pregnancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Progesterone (vaginal) (progesterone)

Snippet

Sponsor: Aswan University Hospital | Conditions: Twin; Pregnancy, Affecting Fetus or Newborn | NA | Status: UNKNOWN